The administration seeks to delay the recriminalization of hemp products to December 11, providing a lifeline to the industry.
The administration announced a plan to delay the scheduled recriminalization of intoxicating hemp products until December 11, a move that provides a temporary reprieve for a $28 billion industry. While the ban was originally set to take effect on November 12, the proposed stopgap funding bill allows the hemp industry another month to find a permanent regulatory solution. This shift in policy has sparked debate among lawmakers, particularly regarding whether the administration is acting in the interest of White House Chief of Staff Susie Wiles, whose son-in-law, Bret Worley, is the CEO of MC Nutraceuticals. While the administration maintains that the decision is based on the best interest of the American people, some Republicans, such as Senator Ted Budd, have questioned the sudden reversal. Critics argue that the hemp products are often marketed to children and lack sufficient regulation. The delay provides a significant economic benefit to states like Texas and North Carolina, where the hemp-derived THC market is currently thriving.